Targeting mechanosensitive cannabinoid receptor 1 with isoflavone prodrugs attenuates atherosclerotic endothelial dysfunction
Abstract Background: Despite therapeutic advances, atherosclerosis remains a major global health challenge. Most current treatments target systemic risk factors rather…